Safety of aerosolized INS 365 in patients with mild to moderate cystic fibrosis: results of a phase I multi-center study.
Noone PG, Hamblett N, Accurso F, Aitken ML, Boyle M, Dovey M, Gibson R, Johnson C, Kellerman D, Konstan MW, Milgram L, Mundahl J, Retsch-Bogort G, Rodman D, Williams-Warren J, Wilmott RW, Zeitlin P, Ramsey B; Cystic Fibrosis Therapeutics Development Research Group.
Noone PG, et al. Among authors: konstan mw.
Pediatr Pulmonol. 2001 Aug;32(2):122-8. doi: 10.1002/ppul.1098.
Pediatr Pulmonol. 2001.
PMID: 11477729
Clinical Trial.